Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment?
Laster AJ, Tanner SB
(2011) Rheum Dis Clin North Am 37
: 323-36, vMeSH Terms: Bone Density Conservation Agents, Bone and Bones, Estrogen Replacement Therapy, Female, Fractures, Bone, Humans, Middle Aged, Osteoporosis, Postmenopausal, Practice Guidelines as Topic, Risk Factors, Substance Withdrawal SyndromeAdded January 20, 2015
11 MeSH Terms
The ethics of placebo in studies with fracture end points in osteoporosis.
Stein CM, Ray WA
(2010) N Engl J Med 363
: 1367-70; discussion e21MeSH Terms: Bone Density Conservation Agents, Female, Fractures, Bone, Humans, Osteoporosis, Postmenopausal, Placebos, Randomized Controlled Trials as TopicAdded December 10, 2013
7 MeSH Terms
Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis.
Ryder KM, Tanner SB, Carbone L, Williams JE, Taylor HM, Bush A, Pintea V, Watsky MA
(2010) J Bone Miner Metab 28
: 233-9MeSH Terms: Aged, Biomarkers, Bone Density Conservation Agents, Bone Resorption, Bone and Bones, Calcium, Drug Monitoring, Female, Humans, Hypercalcemia, Hypokinesia, Injections, Subcutaneous, Institutionalization, Male, Middle Aged, Osteogenesis, Osteoporosis, Osteoporosis, Postmenopausal, Persons with Mental Disabilities, Teriparatide, Time Factors, Treatment OutcomeAdded January 20, 2015
22 MeSH Terms
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate.
Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R
(2009) J Womens Health (Larchmt) 18
: 935-43MeSH Terms: Adult, Aged, Aged, 80 and over, Bone Density Conservation Agents, Bone Diseases, Metabolic, Combined Modality Therapy, Diphosphonates, Drug Administration Schedule, Drug Substitution, Female, Humans, Ibandronic Acid, Middle Aged, Osteoporosis, Postmenopausal, Patient Satisfaction, Prospective Studies, Surveys and QuestionnairesAdded January 20, 2015
17 MeSH Terms
Heritability of spinal trabecular volumetric bone mineral density measured by QCT in the Diabetes Heart Study.
Lenchik L, Hsu FC, Register TC, Lohman KK, Freedman BI, Langefeld CD, Bowden DW, Carr JJ
(2004) Calcif Tissue Int 75
: 305-12MeSH Terms: Absorptiometry, Photon, Adult, Aged, Aged, 80 and over, Bone Density, Diabetes Mellitus, Type 2, Female, Genetic Predisposition to Disease, Humans, Inheritance Patterns, Male, Middle Aged, Nuclear Family, Osteoporosis, Postmenopausal, Spine, Tomography, X-Ray ComputedAdded February 15, 2014
16 MeSH Terms
[Bone mass regulation by leptin: a hypothalamic control of bone formation].
Elefteriou F, Karsenty G
(2004) Pathol Biol (Paris) 52
: 148-53MeSH Terms: Adipocytes, Adrenergic beta-Antagonists, Animals, Body Weight, Bone Development, Energy Metabolism, Homeostasis, Humans, Immunity, Innate, Leptin, Mice, Mice, Obese, Neurons, Obesity, Organ Size, Osteoblasts, Osteoporosis, Postmenopausal, Receptors, Adrenergic, beta, Receptors, Leptin, Sympathetic Nervous System, Ventromedial Hypothalamic NucleusAdded November 14, 2013
21 MeSH Terms